Drug Channels

NOVEMBER 13, 2024

As I predicted, the stand-alone Medicare Part D prescription drug plans (PDP) market is vanishing. What’s more, the share of plans with a preferred cost sharing pharmacy network will fall to its lowest rate in more than 10 years. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Pharmacy 86

Pharmacy Marketing Drugs 86

Drug Channels

JANUARY 23, 2024

In a previous article , I highlighted the largest pharmacy chains that will participate in the 2024 Medicare Part D prescription drug plans (PDP). As you will see below, the largest PSAOs have effectively abandoned PDP’s preferred networks in 2024. Look out below! All rights reserved.

Pharmacy 62

Pharmacy Independent Pharmacies Marketing Drugs 62

Drug Channels

JUNE 12, 2024

The 340B contract pharmacy market shows little sign of slowing down. Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. For an updated look at what’s next for the 340B contract pharmacy market, join Adam J. Fein, Ph.D.,

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Marketing 52

Drug Channels

OCTOBER 9, 2024

As regular readers of Drug Channels know, U.S. distribution and dispensing channels for prescription drugs are undergoing significant evolution and consolidation as the changing economics of pharmaceuticals challenge conventional business models. drug wholesaling industry. All rights reserved.

Pharmacy 78

Pharmacy Drugs Pharmaceuticals Hospitals 78

Drug Channels

FEBRUARY 27, 2024

In this issue: An update on the retail pharmacy shakeout Arguing for high drug prices A leading researcher provides a 340B reality check Physicians don’t want pharmacists getting uppity Plus, Dave Grohl fights for your right to…have healthcare price transparency? (I Sorry, no Threads.) All rights reserved.

Pharmacy 69

Pharmacy Drugs Research International 69

Drug Channels

APRIL 1, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. Despite skyrocketing sales for anti-obesity GLP-1 drugs, many retail pharmacies are losing money on every prescription. Click here to see the original post from December 2023.

Pharmacy 86

Pharmacy Hospitals Pharmaceuticals Drugs 86

Drug Channels

JUNE 18, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. Click here to see the original post from April 2024. Last week, we documented the substantial concentration of dispensing revenues for specialty drugs.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Drugs Production 52

Drug Channels

AUGUST 6, 2024

In the video excerpt below, I walk through a brief history of 340B contract pharmacies. I conclude with a “follow the dollar” example of 340B prescription economics with contract pharmacies. I conclude with a “follow the dollar” example of 340B prescription economics with contract pharmacies. All rights reserved.

Pharmacy 52

Pharmacy Hospitals Marketing Drugs 52

Drug Channels

DECEMBER 5, 2023

Consider two apparently unrelated drug channel anomalies: In McKesson’s 2023 fiscal year, CVS bought $75 billion in pharmaceuticals from McKesson’s wholesale business—a jump of more than 35% compared with the previous year. Despite skyrocketing sales for anti-obesity GLP-1 drugs, many retail pharmacies are losing money on every prescription.

Pharmacy 83

Pharmacy Drugs Hospitals Pharmaceuticals 83

Drug Channels

MARCH 25, 2024

It’s finally spring in Philadelphia, home of Drug Channels. What’s ahead for the drug channel? Find out during Drug Channel Implications of the Inflation Reduction Act , a new live video webinar with Adam J. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Specialty Pharmacies 74

Specialty Pharmacies Pharmacy Hospitals Drugs 74

Drug Channels

MARCH 12, 2024

Next week, Drug Channels Institute (DCI) will release our 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. drug pricing, reimbursement, and dispensing system. We’re offering special discounted pricing if you order before April 7, 2024. For 2023, DCI estimates that U.S. to 1:30 p.m.

Pharmacy 80

Pharmacy Marketing Drugs 80

Drug Channels

SEPTEMBER 11, 2024

Time for DCI’s annual update on the channels for provider-administered drugs. Below, I review the latest data on 2024 trends and compare them to the pre-pandemic figures. However, provider pushback has limited specialty pharmacies' share gains, so that buy-and-bill remains the most common channel for these products.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 52

Drug Channels

APRIL 24, 2024

Last week, we documented the substantial concentration of dispensing revenues for specialty drugs. See The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents. In those exclusive networks, independent and smaller specialty pharmacies are the big winners.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Production Drugs 52

Drug Channels

APRIL 16, 2024

Drug Channels Institute’s (DCI’s) latest analysis finds that participants in the specialty pharmacy market continue to get more diverse—although revenues remain highly concentrated. Read on for DCI’s latest overview of the 2023 marketplace and revenues of the biggest market participants, along with key specialty pharmacy trends.

Specialty Pharmacies 71

Specialty Pharmacies Pharmacy Marketing Hospitals 71

Common Sense for Drug Policy Blog

JUNE 7, 2024

Community Pharmacies and Harm Reduction "Community pharmacies are essential healthcare destinations that serve as an optimal resource for addressing non-urgent inquiries, such as safe injecting practices, management of adverse drug reactions, and medication provision, thus reducing the burden on general practitioners (GPs) [ 1 , 2 ].

Community Pharmacies 52

Community Pharmacies Pharmacy Treatment Drugs 52

Drug Channels

APRIL 29, 2024

on how Medicare Part D plans will react to the Inflation Reduction Act Walgreens' unexpected specialty pharmacy strength A video deconstruction of my infamous Drug Channels article on GoodRx Plus, a cartoonist illustrates my recent keynote on the battle for oncology margin.

Specialty Pharmacies 81

Specialty Pharmacies Pharmacy Biosimilars Drugs 81

Drug Channels

NOVEMBER 14, 2023

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: Drug Channels Outlook 2024 This event will be broadcast live on Friday, December 15, 2023 12:00 p.m. This event is part of The Drug Channels 2023 Video Webinar Series. Dr. Adam J.

Pharmacy 76

Pharmacy Biosimilars Drugs Marketing 76

Drug Channels

APRIL 4, 2024

This week, I’m rerunning some popular posts while I prepare for tomorrow’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. For updated data on hospital-owned specialty pharmacies, see Chapter 3 of DCI's new 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Hospitals International 52

Drug Channels

OCTOBER 24, 2023

Open enrollment is under way for the 2024 Medicare Part D plans. Our exclusive analysis of Center for Medicare & Medicaid Services’ (CMS) data reveals that preferred cost sharing pharmacy networks will maintain their dominance as a component of Part D benefit design. The 2024 data provide early evidence of a shrinking PDP market.

Pharmacy 52

Pharmacy Independent Pharmacies Marketing Drugs 52

Drug Channels

JUNE 18, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. billion figure was roughly accurate for the AllianceRx Walgreens Pharmacy business. Click here to see the original post from April 2024. All rights reserved.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Marketing Hospitals 52

FDA Law Blog: Biosimilars

MAY 30, 2024

Kirschenbaum — Last week, the United States Court of Appeals for the District of Columbia ruled that Section 340B of the Public Health Service Act does not prohibit pharmaceutical manufacturers from imposing conditions on the distribution of discounted drugs to covered entities in the program. In United Therapeutics Corporation v.

Pharmacy 57

Pharmacy Pharmaceuticals Drugs Government 57

Drug Channels

APRIL 2, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. For more on acquisition cost reimbursement for pharmacies, see Sections 8.4. of our new 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers.

Pharmacy 64

Pharmacy Drugs 64

FDA Law Blog: Biosimilars

MARCH 24, 2024

By Faraz Siddiqui — As drug manufacturers battle the Health Resources and Services Administration (“HRSA”) in federal courts over the role of 340B contract pharmacies, an Eighth Circuit decision to uphold a 2021 Arkansas law may render those cases inconsequential in that state. Code Ann. § 23-92-604(c)(1), (2) (Act 1103).

Pharmacy 57

Pharmacy Regulations Compliance Drugs 57

Drug Channels

APRIL 9, 2024

Three is still the magic number for pharmacy benefit managers (PBMs). Read on for Drug Channels Institute’s (DCI’s) latest market share figures, along with a preview of the industry changes that will shift these shares over the next few years. All rights reserved. This Feed is for personal non-commercial use only.

Pharmacy 91

Pharmacy Marketing Drugs 91

Drug Channels

APRIL 18, 2024

Today’s guest post comes from Jim Sheninger, Pharmacy Strategy Officer at GoodRx. Jim describes GoodRx's emerging pharmacy contracting strategies. In addition to working through pharmacy benefit managers (PBMs), GoodRx now also contracts directly with Walgreens, CVS, and other national and regional pharmacies.

Pharmacy 52

Pharmacy Drugs 52

Drug Channels

NOVEMBER 28, 2023

In this issue: A reality check on Express Scripts’ purported “cost-based” pharmacy network Mark Cuban explains how and why the PBM market will change Why two drug prices are better than one Pharmacists sing the retail pharmacy shakeout blues Plus, two Philly legends meet at a cardiology conference! d/b/a Drug Channels Institute.

Pharmacy 75

Pharmacy Drugs Marketing 75

Drug Channels

DECEMBER 6, 2023

Is the world ready for new ways to price pharmacy and pharmacy benefit manager (PBM) services? I commend CVS Health for attempting to address key economic challenges facing the retail pharmacy industry and for tackling the hidden complexities of PBM pricing models. d/b/a Drug Channels Institute. Et tu, Walgreens?)

Pharmacy 68

Pharmacy Drugs 68

Drugs.com

APRIL 15, 2024

MONDAY, April 15, 2024 -- Americans are facing more shortages of the drugs they need for medical care than ever before, a national pharmacy database shows.The American Society of Health-System Pharmacists (ASHSP) and the University of Utah Drug.

Pharmacy 111

Pharmacy Drugs 111

Drug Channels

JANUARY 30, 2024

But who needs the Super Bowl when you can tackle this month’s selection of notable news stories, intercepted for you from the Drug Channels gridiron: Punt : Average list prices are unchanged for 2024 Trick Play : GSK tussles with PBMs over lower-priced products Rush! Check out the wonderful comments on this LinkedIn post.

Hospitals 76

Hospitals Pharmacy Drugs Production 76

Drug Channels

JANUARY 9, 2024

For 2024, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)—have again each excluded 600 or more drugs from their standard formularies. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Biosimilars 89

Biosimilars Pharmacy Production Drugs 89

Drugs.com

OCTOBER 15, 2024

15, 2024 -- Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national drug shortage. TUESDAY, Oct.

Compounding Pharmacies 89

Compounding Pharmacies Pharmacy FDA Drugs 89

Drug Channels

JUNE 17, 2024

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: The 340B Drug Pricing Program: Trends, Controversies, and Outlook. Click here to see the original post from April 2024. Three is still the magic number for pharmacy benefit managers (PBMs). All rights reserved.

Pharmacy 52

Pharmacy Marketing Drugs 52

Drugs.com

SEPTEMBER 20, 2024

20, 2024 -- The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug Administration on Friday approved FluMist nasal spray as the first influenza vaccine that can be. FRIDAY, Sept.

FDA Approval 116

FDA Approval Vaccine Pharmacy Doctors 116

Drugs.com

SEPTEMBER 20, 2024

20, 2024 -- The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug Administration on Friday approved FluMist nasal spray as the first influenza vaccine that can be. FRIDAY, Sept.

FDA Approval 111

FDA Approval Vaccine Pharmacy Doctors 111

Drug Channels

AUGUST 20, 2024

Have you requested an invite to the inaugural Drug Channels Leadership Forum ? Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Join my nearly 58,000 LinkedIn followers for daily links to neat stuff along with thoughtful and provocative commentary from the DCI community.

Pharmacy 52

Pharmacy Drugs Hospitals 52

Drug Channels

OCTOBER 21, 2024

Informa Connect’s Trade and Channel Strategies December 10-12, 2024 at the W Hotel in Philadelphia, PA Drug Channels readers save 10% with code 24DC10 * Pharmacy and distribution models are growing increasingly complex. Stop running in circles—It’s time to unlock proven strategies to propel market access. Am I still prepared?

Specialty Pharmacies 72

Specialty Pharmacies Pharmacy Marketing Compliance 72

Drug Channels

MARCH 5, 2024

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s latest live video webinar: Drug Channel Implications of the Inflation Reduction Act This event will be broadcast live on Friday, April 5, 2024, from 12:00 p.m. Pharmacies and Pharmacy Benefit Managers.

Pharmacy 84

Pharmacy Biosimilars Drugs Marketing 84